Lobby organisation
Fresenius SE & Co.KGaA
Company · Health & pharma · HQ: Germany · Transparency Register entry
As of 7 November 2026, Fresenius SE & Co.KGaA appears in 14 declared MEP meetings (12 different MEPs), most often with European People's Party.
In their own words
“Fresenius is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In fiscal year 2025, Fresenius generated €22.5 billion in annual revenue with around 178,000 employees (excluding Fresenius Medical Care). As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients.”
Read the rest of the statementShow less of the statement
“The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the Investment Company Fresenius Medical Care. Fresenius Kabi supplies healthcare products for critically and chronically ill patients Fresenius Helios is Europe’s leading private hospital operator […]”
Stated goals from the organisation's own Transparency Register filing - the text on file breaks off mid-sentence where marked […].
Who they meet, and when
Which groups they meet
Share of this organisation's 14 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (7 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 14 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 17 Aug 2026 | Lukas Mandl | EU Biotech Act |
| 5 Mar 2026 | Kristian Vigenin | Biotech Act |
| 4 Mar 2026 | Andreas Glück | Biotech |
| 27 Feb 2026 | Valérie Hayer | Compétitivité |
| 26 Jun 2025 | Pietro Fiocchi | Tematiche ambientali |
| 24 Jun 2025 | Tomislav Sokol | Health policy |
| 7 May 2025 | Angelika Niebler | EU Health Care Policies |
| 29 Apr 2025 | András Tivadar Kulja | Biotech Act, medicines shortages |
| 27 Mar 2025 | Eero Heinäluoma | Biotech and Biomanufacturing |
| 27 Mar 2025 | Stine Bosse | European health policy |
| 24 Jan 2025 | Oliver Schenk | Wettbewerbsfähigkeit der europäischen Pharma-Industrie |
| 17 Sep 2024 | Oliver Schenk | UWWTD |
| 7 Sep 2023 | Tiemo Wölken | Revision of the Pharmaceutical Legislation (staff level) |
| 4 Apr 2023 | Tiemo Wölken | EU-Health Policy with a focus on AMR (staff level) |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.